Rifampicin-resistant tuberculosis
MONDO:0100479A form of drug-resistant tuberculosis that is resisant to rifampicin with or without resistance to other antitubercular medications.
Also known as: RR-TB, rifampicin-resistant TB
25 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can a new TB vaccine protect children with HIV?
⭐️ VACCINE ⭐️ TerminatedThis trial is testing two tuberculosis (TB) vaccines—VPM1002 and a repeat BCG vaccination—in pre-adolescents aged 8-14 who were vaccinated at birth. The goal is to see if these vaccines are safe and trigger a strong immune response in children both with and without HIV, and in th…
Phase: PHASE1, PHASE2 • Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 18, 2026 08:00 UTC
-
New hope for Drug-Resistant TB: a 6-Month pill regimen
Disease control OngoingThis phase 3 trial is testing a 6-month, all-oral combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin or clofazimine) to treat rifampin-resistant tuberculosis in Chinese teenagers and adults aged 12 and older. The goal is to see if this shorter regimen …
Phase: PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC